Resveratrol has antioxidant and anti-inflammatory potential, it is platelet antiaggregant, protects the vascular endothelium of the harmful action of cholesterol and triglycerides, improves lipid metabolism, and has anti-cancer activity by inhibiting the proliferation of several types of cancer cells. The therapeutic benefits have been proven in coronary, neurological, hepatic, cardiovascular disease and even cancer. Resveratrol stimulates the release of nitric oxide in blood vessels, inducing vasodilatation, inhibit monocyte adhesion and proliferation of vascular smooth muscle. Several studies have shown that resveratrol has cardioprotective effect in myocardial damage induced by pharmacological models of myocardial infarction. It is considered that a daily dose of 200-400 mg of resveratrol may be beneficial in inflammatory diseases, metabolic syndrome and type II diabetes, against aging and cardiovascular disease. Also, resveratrol was able to prevent or retard the growth of malignant cells both in vivo and in vitro.